Morgan Stanley CEO: coronavirus will continue to pose challenges
April 17, 2020Most U.S. firms have no plans to leave China due to coronavirus: survey
April 17, 2020Report says COVID-19 patients respond to Gilead’s remdesivir, shares surge
at
Gilead Sciences Inc’s shares surged 16% in after hours trading on Thursday following a media report detailing encouraging partial data from trials of the U.S. company’s experimental drug remdesivir in severe COVID-19 patients.
Powered by WPeMatico
